Venture Capital

Introducing The British Innovation Fund II

NURTURING SUSTAINABLE INNOVATIONS:
A ONE HEALTH APPROACH TO FOOD, HEALTH, AND PLANET

Building upon the success of The British Innovation Fund I, the British Innovation Fund II continues to invest in high-potential companies emerging from the rich ecosystem of University Venturing. With a keen focus on agri-tech, the future of healthcare, climate impact, and alternative protein sectors, the fund is dedicated to supporting ventures where incontrovertible science forms the bedrock of the commercial proposition. This initiative embodies a One Health approach, underscoring the intrinsic connections between Food, Health, and Planet, and striving for sustainable solutions through innovative ventures.

Our Investments

BugEra

Advancing the biofuel industry with Modified Black Soldier Fly strains for sustainable bi-products.

52 North Health

Revolutionising patient care by swiftly identifying chemotherapy patients at risk of neutropenic sepsis, chemotherapy patients at risk of neutropenic sepsis, optimising healthcare resources and saving lives.

Cody Genetics

Harnessing gene-editing technology to enhance livestock farming, promoting animal welfare and resource efficiency.

Learn More

Jiva.ai

Utilising a model fusion approach to machine learning for creating diagnostic solutions to human diseases.

Learn More

Roslin Technologies

Pioneering animal stem cell solutions to support the global cultivated meat market and promote sustainable food production.

Learn More

Attomarker

Offering a unique COVID-19 triple antibody testing device to provide real-time immunity analysis.

Learn More

Polymateria

Providing biodegradable solutions for conventional plastic packaging to combat global plastic pollution.

Learn More

IRNovate

Revolutionising liver biopsy procedures to enhance safety and acceptance, thereby advancing the understanding and treatment of liver disease.

Green Bioactives

Harnessing natural bioactives for innovative, eco-friendly solutions in agriculture and healthcare.

Oncoshot

Facilitating precise cancer care pathways by connecting patients and doctors to advanced treatment options and clinical trials.

Eupnoos

Pioneering real-time breathing analysis technology to enhance respiratory care and diagnostics.

Learn More

Shandi

Leader in plant-based culinary innovation. They have rapidly emerged as a trailblazer in plant-based food technology, leading the way in the alternative protein sector.

Team

Advisers

Introducing Green Earth Ventures

Green Earth Ventures is a venture capital fund investing in high potential late seed and series A companies focused on food production, waste management, and resource management, critical to creating a more sustainable, cleaner, and healthier future.

We aim to improve 3 sectors:
– Animal: Decarbonising livestock production
– Plant: Sustainable crop protection and nutrition
– Waste: Elimination and repurposing of waste

Our Pre-Seeded Investments

Bugera

BugEra improve the natural traits of the Black Soldier Fly (BSF) through genetic engineering – creating a Modified Black Soldier Fly (M-BSF). This allows BugEra to rapidly develop novel strains to deliver an array of safe and sustainable bi-products. Backed by global leader in the production of biofuel, BugEra's first strain is already delivering for the rapidly expanding biofuel industry, decarbonising transport sectors such as aviation and shipping.

Learn More

Cody Genetics

Founded in 2021, Cody Genetics is an animal biotechnology company that applies gene-editing technology to benefit livestock farming. The company enables breeders to receive sperm/oocytes that not only will have a pre-determined sex, but that in turn will only produce gender-biased offspring through unassisted reproduction. The gene-editing technology offered by Cody dramatically improves animal welfare by preventing the culling of billions of animals and immensely reduces resource-use.

Learn More

Roslin Technologies

Roslin Technologies is a biotech company pioneering sustainable solutions to support the food and agriculture sectors. Its mission is to advance disruptive innovations to improve how we produce proteins to feed the world’s increasing population. Its primary focus is on animal stem cells – and their huge potential as ingredients for supporting the global cultivated meat market..

Learn More

Polymateria

Polymateria provides a tailored biodegradable solution for conventional plastic packaging, aiming to stem the global plastic pollution endemic. In 2020, the privately owned company was the first to achieve certified biodegradation of the most commonly-littered forms of plastic packaging in real-world conditions, in less than a year without creating microplastics.

Learn More

Green Bioactives

Green Bioactives, a University of Edinburgh start-up, have developed innovative strategies to produce plant-derived natural products utilising plant cell culture with full freedom to operate. These technologies can significantly improve the yields of target natural products in cultured plant cells. This technology platform can be employed to produce high quality natural product ingredients for the cosmetic, pharmaceutical, food and agricultural industries.

Learn More

Shandi Global

Shandi Global, a leader in plant-based culinary innovation, has launched a pioneering plant-based chicken as part of their FOREVER range. This product, characterised by high-quality, sustainability, and affordability, is a testament to their commitment to vegan cuisine.

Learn More

Historical Investments

PragmatIC Semiconductors

Cambridge-based PragmatIC is a world leader in ultra-low-cost flexible electronics. Their flexible integrated circuits (FlexICs) are thinner than a human hair and can be invisibly embedded in objects, enabling innovators to create novel solutions to everyday problems that are not practical with conventional electronics.

CorePower

CorePower is a UK-based development company, specializing in scalable atomic power technology for ocean transport and heavy industry. In partnership with leading international corporations, CorePower aims to deliver durable zero-emission energy for floating industrial production and deep-sea shipping.

Green Earth Ventures Team

Advisers

Introducing Future Health

Future Health Fund is a venture capital fund investing in high-potential late seed and series A companies focused on the science of ageing, and diagnostics enabling early detection and management of illness.

Our portfolio also includes innovation within cancer diagnostics, immunisation companies, artificial intelligence, telehealth, and digital mental health solutions.

Our Pre-Seeded Investments

52 North Health

Cambridge medtech start-up 52 North Health has developed an innovative device, Neutrocheck, that rapidly identifies chemotherapy patients at risk of a life-threatening complication called neutropenic sepsis. Through improving triaging, Neutrocheck has the potential to save thousands of lives, free up valuable healthcare resources, and make patients' lives easier, simpler, and better.

Learn More

Jiva.Ai

Jiva.ai is an AI company that uses a model fusion first approach to machine learning to provide a sophisticated platform that enables multi-modal AI, allowing non-technical users to iteratively grow, evolve and deploy models based on their data for real-world use.

Learn More

Attomarker

Attomarker, a spin-out company from the University of Exeter, has produced a unique COVID-19 triple antibody testing device, giving a real-time analysis of immunity levels. The blood sample analysis tracks both the waning immunity from vaccines and ‘natural immunity’ boosts from COVID infections. The data it generates amounts to a personal COVID-risk profile for each individual.

Learn More

IRNovate

IRNovate's VABS is a groundbreaking, single-use device that addresses the limitations and risks of existing liver biopsy methods. It ensures enhanced safety, higher patient acceptance, faster recovery, and increased usage.

Oncoshot

Oncoshot is a health insights exchange platform that leverages its proprietary clinical trial matching artificial intelligence (AI) technology to address the inefficiencies of cancer clinical trials. The platform serves as a bridge between leading regional healthcare institutions and contract research organizations (CROs) and global biotechnology and pharmaceutical companies to facilitate data-driven cancer clinical trials while accelerating enrolment into actively recruiting ones.

Learn More

Eupnoos

Eupnoos is an AI enhanced smartphone app able to use sound to objectively measure lung function in patients diagnosed with chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and interstitial lung disease (ILD).

Learn More

Historical Investments

Viome

Viome is a health testing company that uses artificial intelligence (AI) to analyze an individual’s gut biology to gain insights into their health. The service offers personalized food recommendations and made-to-order supplements according to these test results.

Exit

Vaccitech

Vaccitech (now Barinthus Biotherapeutics) is a biotechnology company developing vaccines and immunotherapies for infectious diseases, specialising in T-cell immunotherapy. Having developed the Oxford/AstraZeneca vaccine and administering over 2B doses globally, the company was listed on NASDAQ in 2021, reaching a peak valuation of $628m.

Exit

Totient

Totient is an artificial intelligence-driven drug discovery platform that identifies and harnesses human-derived antibodies from individuals with exceptional immune responses. Totient was acquired by Absci for an undisclosed amount in 2021.

Exit

AMLo Biosciences

AMLo Biosciences is translating ground-breaking research in cancer biomarkers into a revolutionary range of prognostic and companion diagnostic products to improve patient outcomes and reduce the financial burden of cancers on global healthcare economies.

Exit

MyDoc

MyDoc is Asia’s leading telemedicine service company. MyDoc’s fully integrated online-to-offline platform streamlines all aspects of primary healthcare into one easy-to-use solution connecting patients to doctors, pharmacies, diagnostic laboratories, clinical-grade health trackers, Fortune 500 and SME employers, and insurers.

Exit

Future Health Team

Advisers

Introducing the Asia Sustainable Impact Fund

NURTURING SUSTAINABLE INNOVATIONS:
A ONE HEALTH APPROACH TO FOOD, HEALTH, AND PLANET

Building upon the success of The British Innovation Fund I, the Asia Sustainable Impact Fund invests in high-potential late seed and series A companies from Asia or with significant portion of their revenues coming from Asia, emerging from the rich ecosystem of University Venturing. With a keen focus on agri-tech, the future of healthcare, climate impact, and alternative protein sectors, the fund is dedicated to supporting ventures where incontrovertible science forms the bedrock of the commercial proposition. This initiative embodies a One Health approach, underscoring the intrinsic connections between Food, Health, and Planet, and striving for sustainable solutions through innovative ventures.

Our Investments

BugEra

Advancing the biofuel industry with Modified Black Soldier Fly strains for sustainable bi-products.

Learn More

Cody Genetics

Harnessing gene-editing technology to enhance livestock farming, promoting animal welfare and resource efficiency.

Learn More

Attomarker

Offering a unique COVID-19 triple antibody testing device to provide real-time immunity analysis.

Learn More

Polymateria

Providing biodegradable solutions for conventional plastic packaging to combat global plastic pollution.

Learn More

IRNovate

Revolutionising liver biopsy procedures to enhance safety and acceptance, thereby advancing the understanding and treatment of liver disease.

Oncoshot

Facilitating precise cancer care pathways by connecting patients and doctors to advanced treatment options and clinical trials.

Learn More

Eupnoos

Pioneering real-time breathing analysis technology to enhance respiratory care and diagnostics

Learn More

Shandi Global

Leader in plant-based culinary innovation. They have rapidly emerged as a trailblazer in plant-based food technology, leading the way in the alternative protein sector.

Learn More

Investment Team

Celine Lin
ANALYST & RISK MANAGER
Milltrust Ventures

Discover our Range of Venture Capital Funds

Introducing The British Innovation Fund II

Our Investments

BugEra

52 North Health

Cody Genetics

Jiva.ai

Roslin Technologies

Attomarker

Polymateria

IRNovate

Green Bioactives

Oncoshot

Eupnoos

Shandi

Team

Simon Hopkins

Alexander Kalis

Dr Bernard Ng

Harry Paul

Advisers

Prof Paul Teng

Dr Roger Foo

Dato Kim Tan

Sir David Lane

Dr Saif Ahmad

Dr Ian Yeung

Glen Illing

Prof Brian Kennedy

Introducing Green Earth Ventures

Our Pre-Seeded Investments

Bugera

Cody Genetics

Roslin Technologies

Polymateria

Green Bioactives

Shandi Global

Historical Investments

PragmatIC Semiconductors

CorePower

Green Earth Ventures Team

Simon Hopkins

Alexander Kalis

Harry Paul

Dr Bernard Ng

Advisers

Prof Paul Teng

Glen Illing

Introducing Future Health

Our Pre-Seeded Investments

52 North Health

Jiva.Ai

Attomarker

IRNovate

Oncoshot

Eupnoos

Historical Investments

Viome

Vaccitech

Totient

AMLo Biosciences

MyDoc

Future Health Team

Simon Hopkins

Alexander Kalis

Dr Bernard Ng

Harry Paul

Advisers

Dr Ian Yeung

Dr Roger Foo

Prof Brian Kennedy

Sir David Lane

Dr Saif Ahmad

Introducing the Asia Sustainable Impact Fund

Our Investments

BugEra

Cody Genetics

Attomarker

Polymateria